Argenx
ARGX
#491
Rank
โ‚น4.839 T
Marketcap
โ‚น77,445
Share price
0.81%
Change (1 day)
56.44%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2026 (TTM): โ‚น1,415

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น1,522. In 2024 the company made an earnings per share (EPS) of โ‚น1,340 an increase over its 2023 EPS that were of -โ‚น496.88.

EPS history for Argenx from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น1,415
2024โ‚น1,340-369.77%
2023-โ‚น496.88-60.46%
2022-โ‚น1,25763.33%
2021-โ‚น769.40-40.37%
2020-โ‚น1,290183.47%
2019-โ‚น455.20123.09%
2018-โ‚น204.0554.93%
2017-โ‚น131.7014.07%
2016-โ‚น115.4513.05%
2015-โ‚น102.12-36.34%
2014-โ‚น160.42209.04%
2013-โ‚น51.91-33.99%
2012-โ‚น78.64185.59%
2011-โ‚น27.54